Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...
We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Precigen, Inc. (NASDAQ:PGEN) stands against other hot biotech stocks under $5. The ...
OSE will now pivot to focus on late-stage pipeline development of its cancer vaccine, Tedopi and its anti-inflammatory drug, lusvertikimab.
When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...
O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...
The American Seed Trade Association will be the lead advocate for crop biotechnology now that the Biotechnology Innovation Organization has eliminated its agriculture and environment section. ASTA was ...
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
Dr. Jennifer Levin Carter, CEO and founder of Medzown, shares her experience as a CEO in the biotech industry and gives insights on how women can succeed in the pharmaceutical industry. In this ...
In cancer immunotherapy, the question is rarely whether a drug can activate the immune system. The harder question is whether it can do so without activating it everywhere at once. That distinction ...